Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
China · Delayed Price · Currency is CNY 16.33
-0.23 (-1.39%)
May 21, 2026, 3:04 PM CST
SHE:002932 Revenue
Wuhan Easy Diagnosis Biomedicine had revenue of 70.67M CNY in the quarter ending March 31, 2026, with 1.01% growth. This brings the company's revenue in the last twelve months to 265.79M, down -25.98% year-over-year. In the year 2025, Wuhan Easy Diagnosis Biomedicine had annual revenue of 265.08M, down -24.28%.
Revenue (ttm)
265.79M
Revenue Growth
-25.98%
P/S Ratio
13.49
Revenue / Employee
443.71K
Employees
812
Market Cap
3.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 265.08M | -84.98M | -24.28% |
| Dec 31, 2024 | 350.06M | -399.47M | -53.30% |
| Dec 31, 2023 | 749.54M | -9.78B | -92.88% |
| Jan 1, 2023 | 10.53B | 7.70B | 272.12% |
| Jan 1, 2022 | 2.83B | 1.87B | 195.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition